Prostate Cancer
NICE Recommends ORGOVYX® (Relugolix) as the First Oral ADT Treatment for Hormone Sensitive Prostate Cancer in England
August 15, 2024
Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments.
August 15, 2024
Abiraterone Acetate Versus Enzalutamide Against Chemo-Naïve Castration-Resistant Prostate Cancer With Full-Dose Induction.
August 15, 2024
Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population-based estimates
August 14, 2024
Technical and Ethical Considerations in Telesurgery
August 14, 2024
A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using ProteographTM and Trapped Ion Mobility Mass Spectrometry.
August 14, 2024
Randomized Trial of Transverse vs Vertical Extraction Site Incision After Robotic Radical Prostatectomy.
August 14, 2024
Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy.
August 14, 2024
Genetics of prostate cancer: a review of latest evidence.
August 14, 2024